<?xml version="1.0" encoding="UTF-8"?>
<p id="p0440">Recent investigations have suggested teicoplanin as alternative treatment for COVID-19 after an 
 <italic>in-vitro</italic> assay achieved IC
 <sub>50</sub> value of 1.66 µM, thus proving its efficacy against SARS-CoV-2. These results need to be confirmed through randomized clinical trials, which are still to be conducted.
 <xref rid="b0495" ref-type="bibr">99</xref>, 
 <xref rid="b1015" ref-type="bibr">203</xref>, 
 <xref rid="b1020" ref-type="bibr">204</xref> Using antibiotics to fight viruses, albeit completely ignored, can become useful to treat COVID-19.
 <xref rid="b1025" ref-type="bibr">205</xref>, 
 <xref rid="b1030" ref-type="bibr">206</xref>
</p>
